Karlan B - Search Results

1

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Lubinski J, Neuhausen SL, Lynch HT, Rosen B, Ainsworth P, Moller P, Ghadirian P, Isaacs C, Karlan B, Sun P, Narod SA. Kotsopoulos J, et al. Among authors: karlan b. Gynecol Oncol. 2006 Jan;100(1):83-8. doi: 10.1016/j.ygyno.2005.07.110. Epub 2005 Aug 31. Gynecol Oncol. 2006. PMID: 16137751

2

Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.

McGonigle KF, Karlan BY, Barbuto DA, Leuchter RS, Lagasse LD, Judd HL. McGonigle KF, et al. Among authors: karlan by. Gynecol Oncol. 1994 Oct;55(1):126-32. doi: 10.1006/gyno.1994.1261. Gynecol Oncol. 1994. PMID: 7959253

3

No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews.

Abrahamson J, Moslehi R, Vesprini D, Karlan B, Fishman D, Smotkin D, Ben David Y, Biran H, Fields A, Brunet JS, Narod SA. Abrahamson J, et al. Among authors: karlan b. Cancer Res. 1998 Jul 15;58(14):2919-22. Cancer Res. 1998. PMID: 9679945

4

Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.

Karlan BY, Baldwin RL, Lopez-Luevanos E, Raffel LJ, Barbuto D, Narod S, Platt LD. Karlan BY, et al. Am J Obstet Gynecol. 1999 Apr;180(4):917-28. doi: 10.1016/s0002-9378(99)70663-0. Am J Obstet Gynecol. 1999. PMID: 10203660

5

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.

Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. Moslehi R, et al. Among authors: karlan b. Am J Hum Genet. 2000 Apr;66(4):1259-72. doi: 10.1086/302853. Epub 2000 Mar 16. Am J Hum Genet. 2000. PMID: 10739756 Free PMC article.

6

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

7

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.

Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J, Weber B, Karlan B, Fishman D, Rosen B, Tung N, Neuhausen SL. Narod SA, et al. Among authors: karlan b. Lancet. 2001 May 12;357(9267):1467-70. doi: 10.1016/s0140-6736(00)04642-0. Lancet. 2001. PMID: 11377596

8

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.

Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dubé MP, Kieback DG, Narod SA. Runnebaum IB, et al. Among authors: karlan b. Pharmacogenetics. 2001 Oct;11(7):635-8. doi: 10.1097/00008571-200110000-00010. Pharmacogenetics. 2001. PMID: 11668223

9

Cancer incidence in a population of Jewish women at risk of ovarian cancer.

Liede A, Karlan BY, Baldwin RL, Platt LD, Kuperstein G, Narod SA. Liede A, et al. J Clin Oncol. 2002 Mar 15;20(6):1570-7. doi: 10.1200/JCO.2002.20.6.1570. J Clin Oncol. 2002. PMID: 11896106

10

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters